-
Sector Analysis
NewSouth Korea Source Tourism Insight by Domestic and Outbound Tourism, Key Destinations and Tourist Profiles, 2024 Update
South Korea Source Tourism Report Overview The total outbound trips from South Korea during 2023 reached 23.17 million, which was still around 80% of 2019 numbers. This trend is largely attributed to the reopening of the borders and relaxation of travel measures. International travel recovery from South Korea has been stable and is expected to grow, with numbers indicating that it will surpass pre-pandemic levels by the end of 2024. The South Korean tourism market is going to rely heavily...
-
Analyst Opinions
NewLuxury Travel – Key Trends and Market Analysis by Destinations, Challenges and Opportunities, 2024 Update
Luxury Travel Market Report Overview The luxury travel market includes lodging, airlines, travel agencies, and destinations. The luxury travel industry is anticipated to benefit from the growing number of high-net-worth individuals as this will help tourists take advantage of and enjoy upmarket products and services on subsequent trips. Post the relaxation of COVID-19-induced travel restrictions, the luxury travel industry has reinforced its outlook and started prioritizing customer experiences rather than material belongings. In addition to embracing sustainability and responsible travel...
-
Product Insights
Likelihood of Approval Analysis for Familial Amyloid Cardiomyopathy
Overview How likely is it that the drugs in Familial Amyloid Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Familial Amyloid Cardiomyopathy Overview Familial amyloid cardiomyopathy (FAC), or transthyretin amyloid...
-
Product Insights
Likelihood of Approval Analysis for Upper Limb Muscle Spasticity
Overview How likely is it that the drugs in Upper Limb Muscle Spasticity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Upper Limb Muscle Spasticity Overview Spasms or spasticity is a...
-
Product Insights
Likelihood of Approval Analysis for Apnea
Overview How likely is it that the drugs in Apnea will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Apnea Overview Sleep apnea is a disorder that causes you to stop breathing...
-
Product Insights
Likelihood of Approval Analysis for Anesthetic Effect
Overview How likely is it that the drugs in Anesthetic Effect will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anesthetic Effect Overview Anesthesia or anaesthesia is a state of controlled, temporary...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – S-1226 in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - S-1226 in Asthma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. S-1226 in Asthma Drug Details: S-1226 is under development for the treatment of...
-
Analyst Opinions
Snacks Demand Spaces and Top Trends
Reasons to buy the ‘Snacks Demand Spaces and Top Trends’ report: Gain access to the most impactful snacking trends driven by emerging consumer behavior with the help of GlobalData's TrendSights Framework. Explore and identify how to leverage the top trends in snack demand spaces in 2024. Understand consumer attitudes and behaviors based on the "five Ws": the who, what, when, where, and whys. Understand how innovation programs, new product development, and new concepts and ideas fit into - or challenge...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onabotulinumtoxin A in Chronic Obstructive Pulmonary Disease (COPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Chronic Obstructive Pulmonary Disease (COPD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Chronic Obstructive Pulmonary Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onabotulinumtoxin A in Myofascial Pain Syndrome (Chronic Myofascial Pain)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Myofascial Pain Syndrome (Chronic Myofascial Pain) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Myofascial Pain Syndrome...